Retractable Technologies, Inc.
http://www.retractable.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Retractable Technologies, Inc.
BD Has Paid Enough In False-Ad Suit, Appeals Court Says
Becton Dickinson won’t need to pay more to resolve a long-running false-advertising case, a federal appeals court has ruled in a split decision.
Prevention/Innovation Key To Driving Down Hospital Infections
The US market for infection control and biosafety products will see strong growth ahead as hospitals continue the battle against health care-associated infections with innovative products and services designed to prevent needlesticks, nosocomial infections, and the spread of antibiotic-resistant organisms.
Boehringer Files Pradaxa Antidote, Could Lead To Reversible Novel Anticoagulant
Finishing off a rolling BLA, company believes that the specific antidote for its novel anticoagulant Pradaxa will be eligible for accelerated approval based on Phase I data in volunteers.
Boehringer Files Pradaxa Antidote, Could Be First Reversible Novel Anticoagulant
Finishing off a rolling BLA, company believes that the specific antidote for its novel anticoagulant Pradaxa will be eligible for accelerated approval based on Phase I data in volunteers.
Company Information
- Industry
- Medical Devices